D. Maciejewski et al., REGULATION OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN EXPRESSION IN CULTURED RAT ASTROCYTES, The Journal of pharmacology and experimental therapeutics, 278(2), 1996, pp. 455-461
The regulation of brain corticotropin-releasing factor (CRF)-binding p
rotein (BP), an endogenous modulator of the CRF family of neuropeptide
s, has been difficult to pursue due to a lack of basal expression in a
known cell line or primary cells in vitro. In light of the ability of
intracellular factors to modulate neuronal and glial function, we exa
mined the effects of a variety of signal transduction modulators on CR
F-BP expression in cultured astrocytes. In particular, the effect of a
gents that stimulate protein kinase A and protein kinase C pathways wa
s evaluated. CRF-BP was measured using a ligand immunoradiometric assa
y. Forskolin, dibutyryl cyclic AMP and 3-isobutyl-1-methylxanthine tre
atment resulted in a dose-dependent increase in CRF-BP levels detected
in the medium from astrocytes and neurons. The increase in CRF-BP exp
ression was not due to increased cell proliferation as measured by [H-
3]thymidine incorporation. In addition, treatment of the astrocytes wi
th phorbol myristate acetate, a protein kinase C activator, caused a r
obust increase in CRF-BP levels in the medium. Steroids such as dexame
thasone, corticosterone, hydrocortisone and, to a lesser extent, dehyd
roepiandosterone inhibited the stimulated release of CRF-BP from astro
cytes. These data define a primary role for intracellular messengers i
n regulating CRF-BP expression in neurons and astrocytes.